CORDIS launches Finnish Presidency R&D and Innovation Information Service

CORDIS, the Community Research and Development Information Service, has launched a new online service covering the research and innovation activities carried out under the Finnish Presidency of the Council of the European Union (1 July to 31 December 2006). Highlighting the latest news and most relevant developments in the research and development (R&D) policy sphere during this period, the Finnish Presidency Service is part of the gateway to national and regional activities on CORDIS.

Particular emphasis is placed on the Finnish research and innovation programme during the country's time at the helm. During its six-month Presidency, Finland's main aim will be to successfully conclude the negotiations on the Seventh R&D Framework Programme (2007 - 2013). Furthermore, agreement to start work on the International Thermonuclear Experimental Reactor (ITER) project will be sought.

In more general terms, Finland intends to work towards improving the EU's global competitiveness and R&D capacities. Particular emphasis is also put on Europe's innovative capacities and on developing markets to create more demand for innovation.

Throughout the Presidency, there will be numerous events, ranging from formal and informal ministerial meetings to open conferences, to support Finnish efforts to develop and strengthen the European innovation environment. Many events will also support and improve cooperation in innovation and research policy and between researchers and financing organisations.

The CORDIS Finnish Presidency Service is a central gateway to R&D and innovation activities carried out during the Finnish Presidency. It provides up-to-date information on policy initiatives, and highlights the latest R&D developments in a dedicated news section. Visitors to the site can also stay informed about upcoming and recent events organised by Finland.

Links to other relevant websites, notably those of the Finnish R&D and innovation actors, provide readers with important resources for further information about the R&D and innovation sector in one of the world's most innovative countries. Analyses of the innovation and R&D systems in Finland, as well as a comprehensive projects and results database, are also made available via the national CORDIS service for Finland.

Finally, the 'showcases' will provide an in-depth overview of particularly important initiatives, success stories or developments.

The Finnish Presidency service on CORDIS is therefore a comprehensive gateway for everyone interested in R&D policy in Europe and in Finland over the next six months. It was developed by CORDIS in cooperation with the relevant Finnish authorities and is available in English and Finnish.

For further information please visit:
http://cordis.europa.eu/finland/presidency/home_en.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...